🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Emanuele Zucca is really a lymphoma legend and trailblazer! The IELG has truly transformed our understanding, prognosis and tx strategies for EN B cell NHL. The power of academic collaboration! #18ICML #lymsm

CONGRESS | #18ICML | POSTER Izidore S Lossos Sylvester Comprehensive Cancer Center shares an updated analysis from a phase II study of loncastuximab for the treatment of R/R marginal zone lymphoma. ORR was 85% with a CR rate of 69%, median duration of CR was 13.7 months, 12-month PFS 92.9% Safety was

Lonca + glofi in R/R LBCL Juan P. Alderuccio #18ICML - 41 pts, 55% IPI 3+, 20% prior CAR - no G5 TEAEs, 6 dc'd d/t AEs - 1 G3 CRS, no G3+ ICANS - ORR 93%, DOR NR (25/26 CRs remained in CR) Looking forward to longer f/u. #lymsm

CONGRESS | #18ICML | PRESENTATION Juan Pablo Alderuccio Juan P. Alderuccio Sylvester Comprehensive Cancer Center presents the initial results from LOTIS-7, evaluating loncastuximab tesirine plus glofitamab in patients with R/R #DLBCL. ORR across all dose levels 93.3%, with a CR rate of 86.7%. Most

Impressive results and excellent presentation by Jennifer Crombie, MD Dana-Farber Sylvester Comprehensive Cancer Center

CONGRESS | #18ICML | PRESENTATION Kate Cwynarski Kate Cwynarski UCLH presents 7-year follow-up results from the phase II MARIETTA trial of multi-agent chemotherapy with MATRix and R-ICE followed by TT-ASCT in patients with SCNSL (N = 75). Long-term follow-up results demonstrate

Here are the top 10 trials from the 18th International Conference on Malignant Lymphoma (International Conference on Malignant Lymphoma 2025). Explore data and insights #ICML2025: t.ly/dz8T1 #LARVOL #Hematology #Lymphoma #CancerResearch #Oncology #CancerData #OncologyInsights #18ICML | Graham Collins |

Top Oncologists from 18th International Conference on Malignant Lymphoma (International Conference on Malignant Lymphoma 2025). Explore data and insights #ICML2025: t.ly/dz8T1 #LARVOL #Hematology #Lymphoma #CancerResearch #Oncology #CancerData #OncologyInsights #18ICML | Graham Collins | Ajay Major, MD, MBA |

🚨🚨🚨 📣We have published our 100th paper! ow.ly/tHaG50Wh38y 🎉🎉🎉

I am excited to announce that we Miller Medicine and MiamiProject, have successfully implanted our first patient, RJ, as part of Neuralink's PRIME Study! Thank you Elon Musk for revolutionizing therapies for our patients!

Big thanks to a great team behind this novel & ambitious study Jessica Okosun Kate Cwynarski Graham McIlroy Nicolas Martinez 🇨🇴🇨🇴 #jeffsmith #bethphilips et al CRCTU Haematology Team Birmingham Cancer Research UK Clinical Trials Unit #TAPnetwork Accelerating Clinical Trials Cure Leukaemia Blood Cancer UK Research

I'm looking forward to participating in Karmanos Cancer Institute Annual Lymphoma Symposium and discussing recent advances in CNS lymphomas. #lymphoma #lymsm

This year marks a milestone in the Lymphoma Research Foundation's journey: three decades of advancing lymphoma research, empowering patients, and building a compassionate community united by resilience, determination, and unwavering hope: lymphoma.org/30years #lymphoma30

Amazing meeting today! #ASH #Fight4Hematology

Do you have advanced #cancer that has become worse following treatment, or advanced cancer for which no standard treatment exists? If so, you may be able to join the #ComboMATCH #PrecisionMedicine study. Learn more: bit.ly/ComboMATCH

Delighted to share our review paper on the treatment of MZL published Blood Journals Portfolio. Great collaboration with Ariela Noy MSK Department of Medicine Memorial Sloan Kettering Cancer Center Sylvester Comprehensive Cancer Center UMiami Health System ashpublications.org/blood/article-…

Our group's latest publication demonstrates the correlation between PET/CT-derived body composition and outcome in DLBCL. #DeepLearning #lymsm #lymphoma Sylvester Comprehensive Cancer Center CRANE Lab Craig Moskowitz, MD UMiami Health System ascopubs.org/doi/10.1200/CC…

Catch up on the latest breakthroughs in #HemOnc with our expert-led Post-#EHA2025 & #18ICML Highlights webinars European Hematology Association International Conference on Malignant Lymphoma The #Lymphoma session will be chaired by Dr Caron Jacobson & moderated by Kate Cwynarski & Dr John Kuruvilla REGISTER 👉 us06web.zoom.us/webinar/regist…

Check out the newest ⁦ASH⁩ #ASHImageBank challenge in the current issue of The Hematologist by ⁦Amaya Llorente Chávez, MD⁩ The images are mind blowing!!! A brilliant teaching case. #hemepath ⁦Blood Journals Portfolio⁩ ashpublications.org/thehematologis…

The FDA-AACR Oncology Educational Fellowship provides early-career scientists and clinicians with an opportunity to learn more about drug development and the regulatory review process from FDA Oncology and AACR experts. Apply by Aug 1: brnw.ch/21wUhUu #AACRSciencePolicy